| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |